Literature DB >> 690428

Immunity to experimental Salmonella infection: studies on the protective capacity and immunogenicity of lipopolysaccharide, acetone-killed cells, and ribosome-rich extracts of Salmonella typhimurium in C3H/HeJ and CD-1 mice.

T K Eisenstein, C R Angerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 690428

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  26 in total

Review 1.  Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge.

Authors:  Raphael Simon; Sharon M Tennant; James E Galen; Myron M Levine
Journal:  Vaccine       Date:  2011-05-25       Impact factor: 3.641

2.  Analysis of immunity to infection with Salmonella typhimurium in outbred mice. II. Isolation and immunogenicity of the protective non-O antigenic component from ribosomal vaccine.

Authors:  E Kita; M Emoto; N Katsui; K Nishi; K Yasui; K Yasui; S Kashiba
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

3.  Immunomodulation of the antibody response to lipopolysaccharide in C3H/HeJ mice by complexing with heterologous ribosomes.

Authors:  M Phillips; T K Eisenstein; J Meissler
Journal:  Infect Immun       Date:  1985-04       Impact factor: 3.441

4.  Immunogenicity of ribosomes from enzymatically lysed Streptococcus pyogenes.

Authors:  B A Green; W Johnson
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

5.  Correlation of the duration and magnitude of protection against Salmonella infection afforded by various vaccines with antibody titers.

Authors:  C R Angerman; T K Eisenstein
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

6.  Dissociation of innate susceptibility to Salmonella infection and endotoxin responsiveness in C3HeB/FeJ mice and other strains in the C3H lineage.

Authors:  T K Eisenstein; L W Deakins; L Killar; P H Saluk; B M Sultzer
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

7.  Protection of C3H/HeJ mice from lethal Salmonella typhimurium LT2 infection by immunization with lipopolysaccharide-lipid A-associated protein complexes.

Authors:  J W Killion; D C Morrison
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

8.  Induction of immunoenhancing factors for murine splenocyte cultures by Salmonella typhimurium ribosome and ribonucleic acid extracts.

Authors:  R C Butler; H Friedman; S C Specter; T K Eisenstein
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

9.  Antigenic modification, rosette-forming cells, and Salmonella typhimurium resistance in outbred and inbred mice.

Authors:  N J Bigley; D P Kreps; R A Smith; A Esa
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

10.  Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans.

Authors:  M M Levine; D Herrington; J R Murphy; J G Morris; G Losonsky; B Tall; A A Lindberg; S Svenson; S Baqar; M F Edwards
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.